Univ.-Prof. Dr. Michael Brainin

Brainin, M. (2019). Stroke epidemiology in China: which are the next steps? Lancet Neurology, 18(4): 325-326

Diener, HC.; Sacco, RL.; Easton, JD.; Granger, CB.; Bernstein, RA., Uchiyama, S.; et al. (2019). Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. New England Journal of Medicine, 380 (20): 1906-1917

Martins, S., Sacks, C.; Hacke, W.; Brainin, M.; et.al. (2019). Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurology, 18(7): 674-683

ASPIS Study Group (2018). Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis. Eur J Neurol., 25: 1182-1188

Brainin M. (2018). Stroke units around the world: the success story continues. Lancet, 18: 1970-1971

Brainin M. (2018). Cerebrolysin: a multi-target drug for recovery after stroke. Expert Rev Neurother, 18: 681-687

Brainin, M. (2018). Secondary Stroke Prevention offers now more choices and is critical to reduce the burden of recurrent stroke and death. Hamdan Medical Journal, 11/1: 10.4103/2227-2437228868

Brainin, M. (2018). Prevention of Stroke: Antihypertensives, Cholesterol-Lowering, Drugs, Antithrombotics, Anticoagulation, Carotid Surgery and Stenting. Hamdan Medical Journal, 11/1: 10.4103/2227-2437 228869

Brainin, M. et. al. (2018). Postitionspapier der ÖGSF. neurologisch, Supplementum: 3-15

Brainin, M.; Feigin, V.; Martins, S.; Matz, K.; Roy, J.; Sandercock, P.; Teuschl, Y.; Tuomilehto, J.; Wiseman, A. (2018). Cut stroke in half: Polypill for primary prevention in stroke. Int J Stroke, 25: 633-647

Brainin, M; Teuschl, Y. (2018). Poststroke Neurocognitive Disorders Are Mostly Defined by Strategic Lesions. Stroke, 49/11: 2563-2564

GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 10.1016/S0140-6736(18)32279: 1789-1858

GBD 2017 Population and Fertility Collaborators. (2018). Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 10.1016/S0140-6736(18)32278: 1995-2051

GBD 2017 SDG Collaborators (2018). Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 10: 2091-2138

Jones, KM.; Bhattacharjee, R.; Krishnamurthi, R., Blanton, S.; Barker-Collo ,S.; Theadom, A.; et. al (2018). Determining the feasibility and preliminary efficacy of a stroke instructional and educational DVD in a multinational context: a randomized controlled pilot study. Clincal Rehabilitation, 32: 1086-1097

Mayer, L.; Ferrari, J.; Krebs, S.; Boehme, C.; Toell. T.; Matosevic, B.; Tinchon, A.; Brainin, M. et. al. (2018). ABCD3-I score and the risk of early or 3-month stroke recurrence in tissue- and time-based definitions of TIA and minor stroke. J Neurol, 265: 530-534

Pierot, L; Jayaraman, MV; Szikora, I; Hirsch, JA; Baxter, B; Miyachi, S; et. al. (2018). Standards of Practice in Acute Ischemic Stroke Intervention: International Recommendations. AJNR Am J Neuroradiol, 39/11: E112-E117

Teuschl, Y.; Trapl, M:, Ratajczak, P.; Matz, K.; Dachenhausen, A.; Brainin, M. (2018). Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. PLoS One, :e0192142: 10.1007/s00415-017-8720-8.

The GBD 2016 Lifetime risk of Stroke Collaborators (2018). Global, Regional and Country specific lifetime risks of Stroke, 1990 and 2016. New England Journal of Medicine, 379: 2429-37

Brainin, M. (2018). The Stroke Patient and Cognition. In: Hachinski, V., Treatable and Potentially Preventable Dementia: 91-109, Cambridge Univeristy Press, Cambridge